EVOLENT HEALTH INC - A (EVH:NYSE)
$2.36 0.03 (1.2876%)
Analysed EVOLENT HEALTH INC - A (EVH:NYSE) News Sources
3 of Wall Street’s Favorite Stocks with Open Questions
09-04-2026
yahoo.com
Astrana Health, Evolent Health, Neogen, agilon health, and Fortrea Shares Are Soaring, What You Need To Know
07-04-2026
yahoo.com
Evolent To Release First Quarter 2026 Financial Results on Thursday, May 7, 2026
07-04-2026
yahoo.com
Evolent Health (EVH): Buy, Sell, or Hold Post Q4 Earnings?
07-04-2026
yahoo.com
RadNet, Evolent Health, Illumina, Charles River Laboratories, and Repligen Stocks Trade Down, What You Need To Know
27-03-2026
yahoo.com
3 Small-Cap Stocks We’re Skeptical Of
19-03-2026
yahoo.com
Evolent announces appointment of Archie Mayani as chief product officer
19-03-2026
yahoo.com
3 Unprofitable Stocks We Approach with Caution
13-03-2026
yahoo.com
How The Evolent Health (EVH) Investment Story Is Shifting After Reserves Reset And Higher Leverage
07-03-2026
yahoo.com
AMN Healthcare Services, RadNet, Evolent Health, Repligen, and Amphastar Pharmaceuticals Stocks Trade Down, What You Need To Know
06-03-2026
yahoo.com
What is the current price of EVOLENT HEALTH INC - A (EVH:NYSE)?
The current price of EVOLENT HEALTH INC - A (EVH:NYSE) is $2.36.
EVOLENT HEALTH INC - A (EVH:NYSE) absolute price change since previous trading day?
The absolute price change of EVOLENT HEALTH INC - A (EVH:NYSE) since the previous trading day is $0.03.
EVOLENT HEALTH INC - A (EVH:NYSE) percentage price change since previous trading day?
The percentage price change of EVOLENT HEALTH INC - A (EVH:NYSE) since the previous trading day is 1.2876%.
What is the most recent average sentiment score for EVOLENT HEALTH INC - A (EVH:NYSE)?
The most recent average sentiment score for EVOLENT HEALTH INC - A (EVH:NYSE) is 62 out of 100.
What is the most recent average sentiment for EVOLENT HEALTH INC - A (EVH:NYSE)?
The most recent sentiment for EVOLENT HEALTH INC - A (EVH:NYSE) is .
SEC-8K** Filing Available For EVOLENT HEALTH INC - A (EVH:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.